Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Semaglutide trumps liraglutide for weight loss in nondiabetic overweight or obese patients

Semaglutide trumps liraglutide for weight loss in nondiabetic overweight or obese patients

07 Apr 2022 bởiRoshini Claire Anthony

Nondiabetic adults with overweight or obesity lost more weight when treated with once-weekly semaglutide than once-daily liraglutide, as demonstrated by results of the phase IIIb STEP* 8 trial.

Semaglutide trumps liraglutide for weight loss in nondiabetic overweight or obese patients

07 Apr 2022
Insulin pump, CGM use linked to better glucose control during pregnancy

Insulin pump, CGM use linked to better glucose control during pregnancy

06 Apr 2022
Tech-enabled, team-based approach lowers HbA1c levels in youth with T1D

Tech-enabled, team-based approach lowers HbA1c levels in youth with T1D

05 Apr 2022

In children with type 1 diabetes (T1D), glycated haemoglobin A1c (HbA1c) significantly decreases at 12 months after diagnosis with the help of a technology-enabled, team-based approach to intensified new-onset education involving target setting, continuous glucose monitoring (CGM), and remote data review, results of a study have shown.

Tech-enabled, team-based approach lowers HbA1c levels in youth with T1D

05 Apr 2022
Resistance exercise could improve sleep duration, efficiency

Resistance exercise could improve sleep duration, efficiency

04 Apr 2022 bởiRoshini Claire Anthony

Individuals at elevated cardiovascular disease risk (overweight/obese, increased blood pressure levels) may improve the duration and efficiency of their sleep through regular resistance exercise regimens, according to a study presented at the EPI Lifestyle Scientific Sessions 2022.

Resistance exercise could improve sleep duration, efficiency

04 Apr 2022
Subclinical hyperthyroidism not a risk factor for MACE in PCI patients

Subclinical hyperthyroidism not a risk factor for MACE in PCI patients

04 Apr 2022

Subclinical hyperthyroidism (SHyper) does not independently correlate with major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI), results of a study have shown.

Subclinical hyperthyroidism not a risk factor for MACE in PCI patients

04 Apr 2022